Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 21 | 2008 | 1309 | 1.440 |
Why?
|
Lung Diseases, Obstructive | 7 | 2000 | 311 | 0.460 |
Why?
|
Bronchiolitis Obliterans | 5 | 2006 | 221 | 0.390 |
Why?
|
Cystic Fibrosis | 4 | 2003 | 1294 | 0.310 |
Why?
|
Oseltamivir | 1 | 2008 | 76 | 0.290 |
Why?
|
Waiting Lists | 2 | 2002 | 779 | 0.280 |
Why?
|
Lung | 11 | 2016 | 10099 | 0.280 |
Why?
|
Oxygen Consumption | 7 | 2002 | 1880 | 0.270 |
Why?
|
Asbestos | 4 | 1992 | 251 | 0.270 |
Why?
|
Respiratory Mechanics | 4 | 1998 | 721 | 0.230 |
Why?
|
Living Donors | 2 | 2006 | 647 | 0.230 |
Why?
|
Hemangioma, Capillary | 1 | 2003 | 64 | 0.210 |
Why?
|
Smad4 Protein | 1 | 2024 | 193 | 0.210 |
Why?
|
Lung Diseases | 6 | 2005 | 1944 | 0.210 |
Why?
|
Anaerobic Threshold | 1 | 2002 | 52 | 0.200 |
Why?
|
Cardiac Output | 3 | 2001 | 838 | 0.200 |
Why?
|
Muromonab-CD3 | 2 | 1999 | 104 | 0.200 |
Why?
|
Doxycycline | 1 | 2003 | 349 | 0.190 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2001 | 418 | 0.180 |
Why?
|
Graft Rejection | 6 | 2008 | 4492 | 0.180 |
Why?
|
Vascular Resistance | 3 | 2002 | 939 | 0.170 |
Why?
|
Pulmonary Ventilation | 2 | 1998 | 375 | 0.170 |
Why?
|
Forced Expiratory Volume | 9 | 2006 | 1831 | 0.170 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 223 | 0.150 |
Why?
|
T-Lymphocytes | 10 | 2005 | 10266 | 0.150 |
Why?
|
Antiviral Agents | 2 | 2008 | 3073 | 0.140 |
Why?
|
Perfusion | 1 | 2002 | 1401 | 0.140 |
Why?
|
Lactic Acid | 1 | 2002 | 1140 | 0.140 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 1992 | 760 | 0.140 |
Why?
|
Hypertension, Pulmonary | 4 | 2002 | 1605 | 0.140 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2000 | 365 | 0.140 |
Why?
|
Influenza, Human | 1 | 2008 | 1541 | 0.130 |
Why?
|
Lidocaine | 2 | 1990 | 546 | 0.130 |
Why?
|
Advisory Committees | 1 | 2020 | 797 | 0.130 |
Why?
|
Serum Amyloid P-Component | 1 | 2016 | 46 | 0.130 |
Why?
|
Exercise Test | 8 | 2016 | 2186 | 0.120 |
Why?
|
Killer Cells, Natural | 3 | 1990 | 2211 | 0.120 |
Why?
|
Exercise Tolerance | 2 | 1998 | 846 | 0.110 |
Why?
|
Smoking | 10 | 2000 | 9092 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1436 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2056 | 0.110 |
Why?
|
Health Status | 1 | 2006 | 4091 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 1999 | 744 | 0.110 |
Why?
|
Respiratory Function Tests | 8 | 2016 | 1695 | 0.100 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2014 | 242 | 0.100 |
Why?
|
Postoperative Complications | 4 | 2008 | 15832 | 0.100 |
Why?
|
Pulmonary Emphysema | 2 | 2014 | 689 | 0.100 |
Why?
|
Mental Health | 1 | 2006 | 3275 | 0.100 |
Why?
|
Opportunistic Infections | 2 | 2008 | 375 | 0.090 |
Why?
|
Vital Capacity | 3 | 2006 | 996 | 0.090 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 1992 | 62 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 1999 | 4206 | 0.090 |
Why?
|
Asbestosis | 1 | 1991 | 81 | 0.090 |
Why?
|
Occupational Exposure | 2 | 1992 | 1807 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 664 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.090 |
Why?
|
alpha 1-Antitrypsin Deficiency | 3 | 2008 | 113 | 0.090 |
Why?
|
Hemodynamics | 5 | 2001 | 4194 | 0.090 |
Why?
|
Lung Neoplasms | 6 | 2003 | 13586 | 0.090 |
Why?
|
Survival Analysis | 5 | 2004 | 10101 | 0.080 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2016 | 521 | 0.080 |
Why?
|
Adult | 39 | 2024 | 223646 | 0.080 |
Why?
|
Vasodilation | 3 | 2002 | 967 | 0.080 |
Why?
|
Tandem Repeat Sequences | 3 | 2005 | 183 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2005 | 3252 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 1 | 1990 | 564 | 0.080 |
Why?
|
Pulmonary Gas Exchange | 3 | 1998 | 389 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3968 | 0.080 |
Why?
|
Male | 48 | 2024 | 364719 | 0.070 |
Why?
|
Walking | 1 | 1995 | 1201 | 0.070 |
Why?
|
Dermatomycoses | 1 | 2008 | 45 | 0.070 |
Why?
|
Aspergillus | 1 | 2008 | 95 | 0.070 |
Why?
|
Organ Transplantation | 1 | 1998 | 1176 | 0.070 |
Why?
|
Phenotype | 3 | 2024 | 16726 | 0.070 |
Why?
|
Dyspnea | 2 | 2014 | 1352 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 4 | 1990 | 4058 | 0.070 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2006 | 93 | 0.070 |
Why?
|
Humans | 60 | 2024 | 768166 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2429 | 0.070 |
Why?
|
Total Lung Capacity | 1 | 2006 | 148 | 0.070 |
Why?
|
Middle Aged | 34 | 2016 | 223492 | 0.060 |
Why?
|
Aspergillosis | 1 | 2008 | 242 | 0.060 |
Why?
|
Flow Cytometry | 5 | 1992 | 5902 | 0.060 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2005 | 93 | 0.060 |
Why?
|
Trachea | 3 | 2006 | 1095 | 0.060 |
Why?
|
Hemolysis | 1 | 1987 | 417 | 0.060 |
Why?
|
Female | 41 | 2024 | 397192 | 0.060 |
Why?
|
Bronchial Diseases | 1 | 2005 | 151 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2006 | 420 | 0.060 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 2004 | 75 | 0.060 |
Why?
|
Physical Endurance | 1 | 2006 | 369 | 0.060 |
Why?
|
Stroke Volume | 5 | 2003 | 5622 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2002 | 432 | 0.060 |
Why?
|
Facies | 1 | 2024 | 224 | 0.050 |
Why?
|
Tissue Donors | 2 | 2004 | 2381 | 0.050 |
Why?
|
Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
Cryptorchidism | 1 | 2024 | 153 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2006 | 373 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 652 | 0.050 |
Why?
|
Hand Deformities, Congenital | 1 | 2024 | 175 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 660 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Nitric Oxide | 2 | 2002 | 2146 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Transplantation Chimera | 1 | 2005 | 594 | 0.050 |
Why?
|
Pulmonary Fibrosis | 2 | 2006 | 506 | 0.050 |
Why?
|
Residual Volume | 1 | 2002 | 40 | 0.050 |
Why?
|
Spirometry | 4 | 2002 | 929 | 0.050 |
Why?
|
Oxygen | 4 | 2002 | 4270 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.050 |
Why?
|
Endothelium | 1 | 2003 | 768 | 0.050 |
Why?
|
Sarcoidosis | 2 | 1986 | 535 | 0.050 |
Why?
|
Boston | 3 | 2002 | 9374 | 0.040 |
Why?
|
Nitroprusside | 1 | 2001 | 272 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2001 | 1946 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 1990 | 6395 | 0.040 |
Why?
|
Nifedipine | 1 | 2001 | 220 | 0.040 |
Why?
|
Tracheal Diseases | 1 | 2001 | 118 | 0.040 |
Why?
|
Ventricular Function, Right | 2 | 2003 | 629 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2016 | 65371 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2002 | 438 | 0.040 |
Why?
|
Ribavirin | 2 | 2000 | 395 | 0.040 |
Why?
|
Hospitals, General | 1 | 2024 | 809 | 0.040 |
Why?
|
Growth Disorders | 1 | 2024 | 635 | 0.040 |
Why?
|
Antibodies, Monoclonal | 7 | 1987 | 9263 | 0.040 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 40 | 0.040 |
Why?
|
Patient Selection | 2 | 2001 | 4260 | 0.040 |
Why?
|
Complement C3b | 1 | 1999 | 98 | 0.040 |
Why?
|
Bronchoconstriction | 1 | 1999 | 141 | 0.040 |
Why?
|
Complement Membrane Attack Complex | 1 | 1999 | 105 | 0.040 |
Why?
|
Aerobiosis | 1 | 1998 | 100 | 0.040 |
Why?
|
Respiratory System Agents | 1 | 1998 | 30 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2006 | 2741 | 0.040 |
Why?
|
Complement C4b | 1 | 1999 | 124 | 0.040 |
Why?
|
Helium | 1 | 1998 | 119 | 0.040 |
Why?
|
Complement C4 | 1 | 1999 | 216 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2002 | 990 | 0.040 |
Why?
|
Blood Gas Analysis | 2 | 1998 | 384 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2002 | 12077 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 4 | 1990 | 1353 | 0.040 |
Why?
|
Acute Disease | 3 | 2004 | 7243 | 0.040 |
Why?
|
Administration, Inhalation | 4 | 2002 | 1169 | 0.040 |
Why?
|
Quality of Life | 3 | 2006 | 13490 | 0.040 |
Why?
|
Physical Fitness | 1 | 2001 | 744 | 0.040 |
Why?
|
Survival Rate | 2 | 2004 | 12840 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2002 | 4620 | 0.030 |
Why?
|
Genetic Linkage | 1 | 2002 | 2342 | 0.030 |
Why?
|
Retrospective Studies | 9 | 2008 | 81762 | 0.030 |
Why?
|
Pneumonia | 1 | 2008 | 2163 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 5 | 2001 | 20760 | 0.030 |
Why?
|
Physical Exertion | 1 | 1998 | 668 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2001 | 1525 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2002 | 15454 | 0.030 |
Why?
|
Adolescent | 7 | 2024 | 89169 | 0.030 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.030 |
Why?
|
Aged | 15 | 2016 | 171504 | 0.030 |
Why?
|
Length of Stay | 3 | 1999 | 6498 | 0.030 |
Why?
|
Radiography | 2 | 2014 | 6983 | 0.030 |
Why?
|
Linear Models | 2 | 1995 | 5884 | 0.030 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 1995 | 69 | 0.030 |
Why?
|
Leukocyte Count | 3 | 1983 | 1609 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2006 | 3488 | 0.030 |
Why?
|
Antifungal Agents | 1 | 1999 | 761 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3436 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 1999 | 640 | 0.030 |
Why?
|
Bronchoscopy | 2 | 2001 | 914 | 0.030 |
Why?
|
Infection Control | 1 | 2001 | 985 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 1992 | 1815 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 1999 | 1506 | 0.030 |
Why?
|
Kidney Transplantation | 2 | 1999 | 4262 | 0.030 |
Why?
|
Therapeutic Irrigation | 2 | 1986 | 297 | 0.030 |
Why?
|
Genotype | 2 | 2024 | 13045 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2004 | 39348 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2001 | 986 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 2145 | 0.020 |
Why?
|
Genome, Human | 2 | 2002 | 4446 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 1990 | 6124 | 0.020 |
Why?
|
Respiration | 1 | 1998 | 1665 | 0.020 |
Why?
|
Piperazines | 1 | 2002 | 2554 | 0.020 |
Why?
|
Herpes Zoster | 1 | 2014 | 252 | 0.020 |
Why?
|
Time Factors | 5 | 2002 | 40218 | 0.020 |
Why?
|
Forecasting | 1 | 2001 | 2945 | 0.020 |
Why?
|
Age of Onset | 3 | 2004 | 3347 | 0.020 |
Why?
|
Lod Score | 2 | 2002 | 600 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4648 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8890 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10760 | 0.020 |
Why?
|
Risk Factors | 5 | 2002 | 74944 | 0.020 |
Why?
|
Pedigree | 3 | 2004 | 4539 | 0.020 |
Why?
|
Sex Factors | 1 | 2004 | 10632 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2002 | 277 | 0.020 |
Why?
|
Blood Pressure | 3 | 2001 | 8543 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2650 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1999 | 4833 | 0.020 |
Why?
|
Graft Survival | 1 | 2001 | 3887 | 0.020 |
Why?
|
Postoperative Period | 1 | 1994 | 1826 | 0.020 |
Why?
|
Pleura | 1 | 1991 | 248 | 0.020 |
Why?
|
Cell Separation | 2 | 1987 | 1728 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 897 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2087 | 0.020 |
Why?
|
Mice, Inbred BALB C | 3 | 2006 | 6231 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2004 | 15948 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17569 | 0.020 |
Why?
|
Diatrizoate | 1 | 1987 | 81 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 12543 | 0.020 |
Why?
|
Ficoll | 1 | 1987 | 39 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1990 | 1703 | 0.020 |
Why?
|
Heart Transplantation | 2 | 1998 | 3301 | 0.020 |
Why?
|
Regression Analysis | 3 | 2004 | 6340 | 0.020 |
Why?
|
Cell Migration Inhibition | 1 | 2006 | 97 | 0.020 |
Why?
|
Lymphocytes | 2 | 2006 | 2614 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1991 | 1157 | 0.020 |
Why?
|
Radiography, Thoracic | 2 | 2000 | 1321 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5151 | 0.020 |
Why?
|
Chemokine CXCL9 | 1 | 2006 | 135 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6514 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 13014 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2005 | 16045 | 0.020 |
Why?
|
Heart | 1 | 1998 | 4446 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2014 | 940 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 240 | 0.020 |
Why?
|
Blood Cells | 1 | 1987 | 309 | 0.020 |
Why?
|
Cohort Studies | 1 | 2008 | 41754 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2006 | 311 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2006 | 343 | 0.010 |
Why?
|
High Mobility Group Proteins | 1 | 2005 | 179 | 0.010 |
Why?
|
Exercise | 2 | 1998 | 5955 | 0.010 |
Why?
|
Hemorrhage | 1 | 1996 | 3467 | 0.010 |
Why?
|
Body Mass Index | 1 | 2002 | 13053 | 0.010 |
Why?
|
Ventriculography, First-Pass | 1 | 2003 | 20 | 0.010 |
Why?
|
Critical Care | 1 | 1996 | 2715 | 0.010 |
Why?
|
SOXB1 Transcription Factors | 1 | 2005 | 286 | 0.010 |
Why?
|
Ovalbumin | 1 | 2005 | 677 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1995 | 4541 | 0.010 |
Why?
|
Respiration Disorders | 1 | 1986 | 364 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1987 | 1617 | 0.010 |
Why?
|
Chronic Disease | 4 | 2000 | 9384 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3814 | 0.010 |
Why?
|
Biopsy | 2 | 2008 | 6793 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36535 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1991 | 2568 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1997 | 4978 | 0.010 |
Why?
|
Bronchiectasis | 1 | 2003 | 141 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12465 | 0.010 |
Why?
|
Ventricular Pressure | 1 | 2002 | 210 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1987 | 977 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2002 | 4249 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 1995 | 2599 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42669 | 0.010 |
Why?
|
Administration, Sublingual | 1 | 2001 | 60 | 0.010 |
Why?
|
Diastole | 1 | 2003 | 785 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2006 | 14488 | 0.010 |
Why?
|
United States | 2 | 2020 | 73039 | 0.010 |
Why?
|
Prognosis | 2 | 2004 | 30010 | 0.010 |
Why?
|
alpha 1-Antitrypsin | 1 | 2000 | 169 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1987 | 1801 | 0.010 |
Why?
|
Sulfones | 1 | 2002 | 448 | 0.010 |
Why?
|
Reference Values | 1 | 1987 | 4938 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2002 | 592 | 0.010 |
Why?
|
Bronchial Provocation Tests | 1 | 1999 | 216 | 0.010 |
Why?
|
Complement C3 Convertase, Alternative Pathway | 1 | 1999 | 7 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30238 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1039 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 3284 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1982 | 344 | 0.010 |
Why?
|
Purines | 1 | 2002 | 615 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 59629 | 0.010 |
Why?
|
Child | 2 | 2024 | 80917 | 0.010 |
Why?
|
Genetic Markers | 1 | 2005 | 2603 | 0.010 |
Why?
|
Environmental Exposure | 2 | 1985 | 4543 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2675 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2006 | 3160 | 0.010 |
Why?
|
Bronchitis | 1 | 1998 | 194 | 0.010 |
Why?
|
H-2 Antigens | 1 | 1978 | 359 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1999 | 386 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60066 | 0.010 |
Why?
|
Nitrogen | 1 | 1998 | 345 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2006 | 22379 | 0.010 |
Why?
|
Heart Rate | 2 | 1999 | 4214 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4146 | 0.010 |
Why?
|
Collagen | 1 | 2005 | 2643 | 0.010 |
Why?
|
Acidosis, Lactic | 1 | 1998 | 145 | 0.010 |
Why?
|
Complement Activation | 1 | 1999 | 447 | 0.010 |
Why?
|
Echocardiography | 2 | 2003 | 5047 | 0.010 |
Why?
|
Models, Chemical | 1 | 1999 | 611 | 0.010 |
Why?
|
Heart-Lung Transplantation | 1 | 1997 | 87 | 0.010 |
Why?
|
Isoantigens | 1 | 1979 | 562 | 0.010 |
Why?
|
Body Surface Area | 1 | 1997 | 205 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1982 | 1561 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2006 | 18349 | 0.010 |
Why?
|
Lactates | 1 | 1997 | 401 | 0.010 |
Why?
|
Airway Obstruction | 1 | 2001 | 672 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 2230 | 0.010 |
Why?
|
Family Health | 1 | 2000 | 1255 | 0.010 |
Why?
|
Animals | 6 | 2006 | 169246 | 0.010 |
Why?
|
Phosphorus | 1 | 1997 | 336 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36743 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 3 | 2002 | 18065 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 1995 | 6568 | 0.010 |
Why?
|
Macrophages | 1 | 1990 | 5799 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2000 | 863 | 0.010 |
Why?
|
Thrombophlebitis | 1 | 1995 | 289 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1998 | 1148 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12421 | 0.010 |
Why?
|
Isoantibodies | 1 | 1978 | 681 | 0.010 |
Why?
|
Rats | 1 | 1990 | 23760 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 3628 | 0.010 |
Why?
|
Risk | 1 | 1985 | 9613 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2001 | 14729 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 9561 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2001 | 22291 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2002 | 6316 | 0.010 |
Why?
|
Asthma | 1 | 1991 | 6291 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1997 | 2486 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 1979 | 1997 | 0.010 |
Why?
|
Mice | 4 | 2006 | 82029 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2003 | 3941 | 0.010 |
Why?
|
Neutrophils | 1 | 1982 | 3786 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1997 | 1162 | 0.000 |
Why?
|
Family | 1 | 1999 | 3209 | 0.000 |
Why?
|
Lymphedema | 1 | 1995 | 527 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9615 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1983 | 11244 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1997 | 3780 | 0.000 |
Why?
|
Homeostasis | 1 | 1997 | 3348 | 0.000 |
Why?
|
Prospective Studies | 2 | 2001 | 54926 | 0.000 |
Why?
|
Epitopes | 2 | 1979 | 2528 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6412 | 0.000 |
Why?
|
Multiple Myeloma | 1 | 1978 | 5196 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 1997 | 20227 | 0.000 |
Why?
|
Ascitic Fluid | 1 | 1979 | 189 | 0.000 |
Why?
|
Plasmacytoma | 1 | 1979 | 170 | 0.000 |
Why?
|
Mice, Inbred DBA | 1 | 1979 | 624 | 0.000 |
Why?
|
Prevalence | 1 | 1995 | 15869 | 0.000 |
Why?
|
Antigen-Antibody Reactions | 1 | 1978 | 342 | 0.000 |
Why?
|
Cross Reactions | 1 | 1979 | 828 | 0.000 |
Why?
|
Incidence | 1 | 1995 | 21538 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1978 | 2014 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1978 | 1230 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1979 | 2323 | 0.000 |
Why?
|